SYP and glycogen storage disease VI: This line has been widely used forneurodegenerative diseases after differentiation with agents, such as retinoic acid,that changes its morphology to be similar to primary neurons, with neuritic process,electrical excitability, and synaptophysin-positive synapses, characteristics ofcholinergic and dopaminergic neurons [19].